Siva Prasad Panda

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Traumatic Brain Injury

Inflammatory Response

Mild Cognitive Impairment

Top Venues

Molecular biology reports

BioImpacts : BI

Current pharmaceutical biotechnology

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjesh Kumar, Siva Prasad Panda
Comprehensive In Silico Analysis of Uncaria Tomentosa Extract: Chemical Profiling, Antioxidant Assessment, and CLASP Protein Interaction for Drug Design in Neurodegenerative Diseases. Current computer-aided drug design (2024)
Siva Prasad Panda, Navneet Pachauri, Adarsh Kesharwani, Dsnbk Prasanth, Vikrant Singh
Participation of Lens Proteins and miRs in Traumatic and Inheritance Cataract: A Review on Diagnostic and Therapeutic Approaches for Cataract Management. Current pharmaceutical biotechnology (2024)
Siva Prasad Panda, Vikrant Singh
The Dysregulated MAD in Mad: A Neuro-theranostic Approach Through the Induction of Autophagic Biomarkers LC3B-II and ATG. Molecular neurobiology (2023)
Siva Prasad Panda, Mahamat Sami Adam Mahamat, Malikyahia Abdul Rasool, Dsnbk Prasanth, Idris Adam Ismail, Moyed Abasher Ahmed Abasher, Bikash Ranjan Jena
Inhibitory effects of mixed flavonoid supplements on unraveled DSS-induced ulcerative colitis and arthritis. BioImpacts : BI 13 (1) (2022)
Siva Prasad Panda, P Hemachandra Reddy, Uma Sankar Gorla, Dsnbk Prasanth
Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets. Molecular biology reports 50 (2) (2022)
Siva Prasad Panda, P Hemachandra Reddy, Uma Sankar Gorla, Dsnbk Prasanth
Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets. Molecular biology reports (2022)
Siva Prasad Panda, P Hemachandra Reddy, Uma Sankar Gorla, Dsnbk Prasanth
Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets. Molecular biology reports 50 (2) (2022)
Siva Prasad Panda, Mahamat Sami Adam Mahamat, Malikyahia Abdul Rasool, Dsnbk Prasanth, Idris Adam Ismail, Moyed Abasher Ahmed Abasher, Bikash Ranjan Jena
Inhibitory effects of mixed flavonoid supplements on unraveled DSS-induced ulcerative colitis and arthritis. BioImpacts : BI 13 (1) (2022)
Siva Prasad Panda, Uttam Prasad Panigrahy, Dsnbk Prasanth, Uma Sankar Gorla, Chakravarthi Guntupalli, Deba Prasad Panda, Bikash Ranjan Jena
A trimethoxy flavonoid isolated from stem extract of Tabebuia chrysantha suppresses angiogenesis in angiosarcoma. The Journal of pharmacy and pharmacology 72 (7) (2020)